Posted on March 18th, 2010 by
Breast cancer researchers say they could cut years off the time required to test new drugs for treating certain kinds of tumors under a study about to begin at the University of Minnesota and the Mayo Clinic…
Known as I-SPY2, the study is designed to compare several experimental drugs at once and tailor them to the breast cancer patients who are most likely to benefit…
"This is really a very novel step forward," said Dr. Judy Boughey, a breast cancer surgeon at the Mayo Clinic and one of the study leaders.
Star Tribune, by Maura Lerner, 3/17/2010
You must be logged-in to the site to post a comment.